A zebrafish model for calcineurin-dependent brain function.
A zebrafish model for calcineurin-dependent brain function.
复制标题
DOI:
10.1016/j.bbr.2021.113544
复制
发表时间:
2022-01-07
影响因子:
2.7
通讯作者:
Creton R
中科院分区:
文献类型:
--
作者:
Tucker Edmister S;Ibrahim R;Kakodkar R;Kreiling JA;Creton R
Small-molecule modulators of calcineurin signaling have been proposed as potential therapeutics in Down syndrome and Alzheimer’s disease. Models predict that in Down syndrome, suppressed calcineurin-NFAT signaling may be mitigated by proINDY, which activates NFAT, the nuclear factor of activated T-cells. Conversely, elevated calcineurin signaling in Alzheimer’s disease may be suppressed with the calcineurin inhibitors cyclosporine and tacrolimus. Such small-molecule treatments may have both beneficial and adverse effects. The current study examines the effects of proINDY, cyclosporine and tacrolimus on behavior, using zebrafish larvae as a model system. To suppress calcineurin signaling, larvae were treated with cyclosporine and tacrolimus. We found that these calcineurin inhibitors induced hyperactivity, suppressed visually-guided behaviors, acoustic hyperexcitability and reduced habituation to acoustic stimuli. To activate calcineurin-NFAT signaling, larvae were treated with proINDY. ProINDY treatment reduced activity and stimulated visually-guided behaviors, opposite to the behavioral changes induced by calcineurin inhibitors. The opposing effects suggest that activity and visually-guided behaviors are regulated by the calcineurin-NFAT signaling pathway. A central role of calcineurin-NFAT signaling is further supported by co-treatments of calcineurin inhibitors and proINDY, which had therapeutic effects on activity and visually-guided behaviors. However, these co-treatments adversely increased excitability, suggesting that some behaviors are regulated by other calcineurin signaling pathways. Overall, the developed methodologies provide an efficient high-throughput platform for the evaluation of modulators of calcineurin signaling that restore neural function, while avoiding adverse side effects, in a complex neural system.
登录
查看更多内容
DOI:
10.9758/cpn.2017.15.1.1
发表时间:
2017-02-28
期刊:
Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology
影响因子:
--
作者:
Kocahan S;Doğan Z
通讯作者:
Doğan Z
影响因子:
4
作者:
Liew WC;Orbán L
通讯作者:
Orbán L
影响因子:
14.8
作者:
Bruni G;Rennekamp AJ;Velenich A;McCarroll M;Gendelev L;Fertsch E;Taylor J;Lakhani P;Lensen D;Evron T;Lorello PJ;Huang XP;Kolczewski S;Carey G;Caldarone BJ;Prinssen E;Roth BL;Keiser MJ;Peterson RT;Kokel D
通讯作者:
Kokel D
影响因子:
64.8
作者:
Arron, Joseph R.;Winslow, Monte M.;Crabtree, Gerald R.
通讯作者:
Crabtree, Gerald R.
影响因子:
6
作者:
Castro, Paula;Zaman, Shahid;Holland, Anthony
通讯作者:
Holland, Anthony